eflornithine has been researched along with aspirin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Brzozowski, T; Drozdowicz, D; Konturek, SJ; Majka, J; Polonczyk-Pytko, J | 1 |
| Goldstone, AD; Koenig, H; Lu, CY | 1 |
| Fitzpatrick, LR; Johnson, LR; Tabata, K; Thirumalai, CH; Tseng, CC | 1 |
| Kovach, JS; Svingen, PA | 1 |
| Mori, H; Ohnishi, M; Rahman, KM; Sugie, S; Suzui, N; Wakabayashi, K; Yoshimi, N | 1 |
| Reddy, BS | 1 |
| Conran, P; Hawk, EE; Kelloff, GJ; Kramer, PM; Li, H; Lubet, RA; Pereira, MA; Schut, HA; Steele, VE | 1 |
| Mori, H; Rahman, W; Sugie, S; Suzui, N | 1 |
| Benamouzig, R; Chaussade, S | 1 |
| Gill, S; Sinicrope, FA | 1 |
| Gerner, EW; Hurley, LH; Ignatenko, NA; Lance, P | 1 |
| Bouhadjar, M; Foltzer-Jourdainne, C; Gosse, F; Marescaux, J; Osswald, AB; Raul, F; Soler, L | 1 |
| Marshall, JR | 1 |
| Lynch, PM | 1 |
| Burke, CA; Chick, RC; Cindass, JL; Clifton, GT; Ensley, DC; Hale, DF; Hickerson, AT; Kemp Bohan, PM; Mankaney, G; Peoples, GE; Sohn, V; Vreeland, TJ | 1 |
7 review(s) available for eflornithine and aspirin
| Article | Year |
|---|---|
Chemoprevention of colon cancer by dietary administration of naturally-occurring and related synthetic agents.
Topics: Allyl Compounds; Anethole Trithione; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Arachidonic Acids; Aspirin; Colon; Colonic Neoplasms; Dinoprostone; Disulfides; Eflornithine; Food, Fortified; Ibuprofen; Intestinal Mucosa; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Piroxicam; Pyrazines; Thiones; Thiophenes | 1997 |
[Chemoprevention of colorectal cancer].
Topics: Adenomatous Polyposis Coli; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arthritis, Rheumatoid; Aspirin; Calcium, Dietary; Case-Control Studies; Cohort Studies; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dietary Supplements; Eflornithine; Enzyme Inhibitors; Female; Folic Acid; Hormone Replacement Therapy; Humans; Male; Mice; Mice, Knockout; Middle Aged; Risk Factors; Sulindac; Time Factors; Vitamins | 2002 |
Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Topics: Adenoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Calcium; Clinical Trials as Topic; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Eflornithine; Folic Acid; Humans; Intestinal Mucosa; Selenium; Ursodeoxycholic Acid | 2005 |
A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene.
Topics: Adenomatous Polyposis Coli Protein; Antineoplastic Agents; Aspirin; Base Sequence; Colonic Neoplasms; Eflornithine; Gene Expression Regulation, Neoplastic; Humans; Models, Biological; Molecular Sequence Data; Neoplasms; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-myc | 2005 |
Nutrition and colon cancer prevention.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Colonic Neoplasms; Diet; Dietary Fiber; Eflornithine; Epidemiologic Studies; Humans; Nutritional Physiological Phenomena; Primary Prevention; Risk Factors; Smoking; Sulindac | 2009 |
Chemoprevention of familial adenomatous polyposis.
Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Celecoxib; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colectomy; Cyclooxygenase 2 Inhibitors; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Eflornithine; Evidence-Based Medicine; Humans; Prophylactic Surgical Procedures; Remission Induction; Sulindac | 2016 |
Chemoprevention in familial adenomatous polyposis: past, present and future.
Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Ascorbic Acid; Aspirin; Capsules; Celecoxib; Chemoprevention; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Eflornithine; Erlotinib Hydrochloride; Fatty Acids, Nonesterified; Genes, APC; Humans; Sirolimus; Sulindac; TOR Serine-Threonine Kinases; Vitamins | 2021 |
12 other study(ies) available for eflornithine and aspirin
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Role of polyamines in gastroprotection induced by epidermal growth factor.
Topics: Animals; Aspirin; Dinoprostone; Eflornithine; Epidermal Growth Factor; Ethanol; Gastric Acid; Gastric Mucosa; Indomethacin; Pepsin A; Polyamines; Rats; Rats, Inbred Strains; Stomach; Stomach Diseases; Stress, Physiological | 1991 |
Blood-brain barrier breakdown in cold-injured brain is linked to a biphasic stimulation of ornithine decarboxylase activity and polyamine synthesis: both are coordinately inhibited by verapamil, dexamethasone, and aspirin.
Topics: Animals; Aspirin; Blood-Brain Barrier; Brain; Brain Injuries; Cold Temperature; Cycloheximide; Dactinomycin; Dexamethasone; Eflornithine; Ornithine Decarboxylase; Polyamines; Rats; Rats, Inbred Strains; Verapamil | 1989 |
Relationship between ornithine decarboxylase activity and gastric damage.
Topics: Animals; Aspirin; Eflornithine; Enzyme Induction; Gastric Mucosa; Male; Ornithine Decarboxylase; Rats; Rats, Inbred Strains; Sodium Chloride | 1987 |
Enhancement of the antiproliferative activity of human interferon by polyamine depletion.
Topics: Aspirin; Cell Division; Cell Line; Doxorubicin; Drug Synergism; Eflornithine; Humans; Indomethacin; Interferon Type I; Neoplasms; Ornithine; Polyamines; Putrescine; Tumor Stem Cell Assay | 1985 |
Inhibitory effects of diallyl disulfide or aspirin on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary carcinogenesis in rats.
Topics: Administration, Oral; Allyl Compounds; Animals; Anticarcinogenic Agents; Aspirin; Carcinogens; Corn Oil; Dietary Fats; Disulfides; Eflornithine; Female; Imidazoles; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 1997 |
Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon.
Topics: Animals; Aspirin; Azoxymethane; Colon; Colonic Neoplasms; Dinoprostone; Dose-Response Relationship, Drug; Eflornithine; Male; Precancerous Conditions; Rats; Rats, Inbred F344 | 1999 |
Chemoprevention of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine-induced mammary carcinogenesis in rats.
Topics: Allyl Compounds; Animals; Anticarcinogenic Agents; Aspirin; Benzoflavones; beta-Naphthoflavone; Carcinogens; Disulfides; Drug Antagonism; Eflornithine; Female; Hydroxybenzoates; Imidazoles; Indoles; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 1999 |
Follow-up of tumor development in the colons of living rats and implications for chemoprevention trials: assessment of aspirin-difluoromethylornithine combination.
Topics: 1,2-Dimethylhydrazine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Carcinogens; Cell Transformation, Neoplastic; Chemoprevention; Colon; Colonic Neoplasms; Colonography, Computed Tomographic; Eflornithine; Follow-Up Studies; Male; Rats; Rats, Inbred F344 | 2007 |